View Cart  

Guidance Asks for Tests to Establish Validity of Highly Multiplexed IVDs

Clinical validation of highly multiplexed microbiological/medical countermeasure in vitro nucleic acid-based diagnostic devices (HMMDs) should include a limited prospective, randomized study of patients with symptoms of the infection the device is intended to identify.

To View This Article:


Subscribe To Devices & Diagnostics Letter

Buy This Article Now

Add this article to your cart for $25.00